Andrew S Chi Selected Research

rovalpituzumab tesirine

1/2019

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew S Chi Research Topics

Disease

27	Glioblastoma (Glioblastoma Multiforme) 12/2020 - 07/2009
26	Neoplasms (Cancer) 01/2020 - 07/2009
23	Glioma (Gliomas) 02/2021 - 04/2007
4	Oligodendroglioma 02/2021 - 06/2013
3	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 06/2013
2	Brain Neoplasms (Brain Tumor) 02/2021 - 11/2014
2	Neoplasm Metastasis (Metastasis) 02/2016 - 02/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2016 - 02/2015
1	Lymphoma (Lymphomas) 12/2020
1	Diffuse Intrinsic Pontine Glioma 04/2019
1	Exanthema (Rash) 01/2019
1	Fatigue 01/2019
1	Gastritis 01/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Hyperglycemia 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Edema (Dropsy) 11/2018
1	Adenocarcinoma of Lung 11/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Meningeal Carcinomatosis 02/2016
1	Necrosis 07/2015
1	Hypoxia (Hypoxemia) 07/2015

Drug/Important Bio-Agent (IBA)

12	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 06/2013
9	Biomarkers (Surrogate Marker)IBA 10/2017 - 06/2013
8	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 10/2015
5	alpha-hydroxyglutarateIBA 01/2018 - 12/2015
4	Pharmaceutical PreparationsIBA 12/2020 - 01/2018
4	TIC10 compoundIBA 10/2019 - 01/2017
4	Bevacizumab (Avastin)FDA Link 04/2019 - 01/2013
4	EnzymesIBA 01/2019 - 04/2007
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 11/2013
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 10/2017
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2015
3	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2014
2	Biological ProductsIBA 01/2021 - 11/2018
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2020 - 01/2018
2	dacomitinibIBA 01/2020 - 01/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 10/2017
2	MethyltransferasesIBA 01/2019 - 01/2018
2	iniparibIBA 01/2019 - 10/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 01/2019
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2018 - 12/2015
2	Coenzymes (Enzyme Cofactors)IBA 01/2017 - 12/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 01/2017
2	cediranib (AZD2171)IBA 01/2017 - 11/2013
2	Anaplastic Lymphoma KinaseIBA 02/2016 - 02/2015
2	alectinibIBA 02/2016 - 02/2015
1	Lomustine (CCNU)FDA Link 02/2021
1	Vincristine (Oncovin)FDA LinkGeneric 02/2021
1	Procarbazine (Matulane)FDA Link 02/2021
1	HexokinaseIBA 12/2020
1	epidermal growth factor receptor VIIIIBA 01/2020
1	dipinacoline glutamateIBA 10/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 04/2019
1	Histones (Histone)IBA 04/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2019
1	AntigensIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	rovalpituzumab tesirineIBA 01/2019
1	NVP-BKM120IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	LigandsIBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	O-(6)-methylguanineIBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2017
1	osimertinibIBA 11/2017
1	ProlactinIBA 10/2017
1	CreatineIBA 01/2017
1	tivozanibIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Choline (Choline Chloride)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 09/2016
1	TransferasesIBA 09/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2016
1	NAD (NADH)IBA 09/2016
1	Niacinamide (Nicotinamide)FDA LinkGeneric 09/2016
1	nicotinate phosphoribosyltransferaseIBA 12/2015
1	ProdrugsIBA 10/2015
1	Messenger RNA (mRNA)IBA 07/2015
1	Ouabain (G Strophanthin)IBA 07/2015
1	Digoxin (Digitek)FDA LinkGeneric 07/2015
1	PanobinostatIBA 06/2015
1	Histone Deacetylase InhibitorsIBA 06/2015
1	Antineoplastic Agents (Antineoplastics)IBA 06/2015

Therapy/Procedure

22	Therapeutics 01/2020 - 09/2006
8	Drug Therapy (Chemotherapy) 02/2021 - 06/2013
4	Radiotherapy 04/2019 - 08/2013
2	Precision Medicine 01/2018 - 04/2016
2	Aftercare (After-Treatment) 01/2017 - 01/2012
1	Immunotherapy 10/2020
1	Transplantation 01/2019
1	Heterologous Transplantation (Xenotransplantation) 07/2015
1	Drug Tapering 02/2015